Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Inclusion Criteria: •≥ to 18 yrs of age •Diagnosis of EPC by a Neurologist Exclusion Criteria: * Previous exposure to clobazam prior to presentation * Seizure generalization * Patients who are intubated and on IV sedation such as Versed®, Propofol or Presedex®. * Female subjects who are pregnant and/or breast-feeding * Subject has an unstable and/or serious or psychiatric illness * Subject has an unstable and/or serious medical illness * Subject has any of the following but not limited to conditions: * A life threatening medical condition * Severe sepsis or septic shock * Severe Renal impairment * Severe Hepatic impairment * Sleep apnea * Narrow angle glaucoma * Severe respiratory insufficiency * Myasthenia gravis * Metastatic cancer * Organ failure * Severe progressive nervous system disease * A clinically significant EKG abnormality that would be affected by and/or affect the patient's participation in the trial * Subject has active suicidal ideation at Screening and Baseline visits * Subject has a history of suicidal thoughts or behaviors, which would be indicated by a positive response to questions 4 and/or 5 on the CSSR-S. Exclusionary actions include but are not limited to: * Previous intent to act on suicidal ideation with a specific plan * Previous preparatory acts or behavior * A previous actual attempt, interrupted attempt or aborted suicide attempt * Subject has a history of alcohol and/or substance abuse in the previous 12 months, or the subject is unable to refrain from alcohol and/or substance abuse during the study. * Subject admits to present illicit drug use or has a positive drug screen * Subject is currently enrolled in or has been enrolled in any clinical trial within the past 30 days * Subject has a known allergy to any component of the study medication(s)